Leber's Hereditary Optic Neuropathy
Idebenone Trial

Welcome to the LHON Idebenone Trial Website

This website will provide with you with information about this new trial which is looking at the drug idebenone (SNT-MC17) as a possible treatment in Leber's Hereditary Optic Neuropathy (LHON). It will allow you to check whether you are eligible to take part in this trial and how to contact the research team if you are interested in getting involved.

On our website you can:

We are no longer recruiting new LHON patients into this trial.  The results will be made available when all the data has been analysed.

Newcastle University Logo Newcastle upon Tyne Hospitals Trust Santhera Logo